For purpose of reducing renal accumulation of radioactivity of a known radiopharmaceutical agent, i.e., , demonstrating that the presence of negative charge on the N-terminal amino acid of octreotide is effective to reduce the renal accumulation. This effect can be attributed to the reduction of lipophilicity and also the repulsive force arisen from the negative charge of renal brush border membrane.
In-DTPA (Diethylenetriaminepentaacetic Acid)-Octreotide on Accumulation of Radioactivity in Kidney
, demonstrating that the presence of negative charge on the N-terminal amino acid of octreotide is effective to reduce the renal accumulation. This effect can be attributed to the reduction of lipophilicity and also the repulsive force arisen from the negative charge of renal brush border membrane.
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111 In-DTPA-octreotide; p-carboxy-phenylalanine; renal accumulation 111 In-DTPA (diethylenetriaminepentaacetic acid)-D-Phe 1 -octreotide (D-Phe compound) is clinically used in Europe as a diagnostic agent; however, it is known to cause renal accumulation of radioactivity (radioaccumulation), which significantly impairs the accuracy of diagnosis. 1, 2) It has been reported that introduction of an acidic amino acid at the N-terminal of octreotide such as aspartic acid leads to the reduction of renal radioaccumulation and therefore the presence of negative charge on the N-terminal amino acid would affect the radioaccumulation in kidney. to evaluate the influence of negative charge at the N-terminal amino acid on biodistribution. The introduction of negative charge into the N-terminal Phe revealed to be effective in the reduction of radioaccumulation in kidney.
In the solid phase peptide synthesis, 2-chlorotrityl chloride resin (Nova Biochem, EMD Biosciences, Inc., Darmstadt, Germany) was used. Protected amino acids such as 9-fluorenylmethoxycarbonyl-L-phenylalanine (Fmoc-Phe-OH) were obtained from Peptide Institute, Inc. (Minoh, Japan). Fmoc-p-carboxy-L-Phe(O t Bu)-OH was purchased from Bachem AG (Bubendorf, Switzerland) and used as it is. The other reagents used in the synthesis were mainly of analytical or reagent grade.
DTPA-L-Phe 1 -octreotide and DTPA-p-carboxy-L-Phe 1 -octreotide were synthesized according to the solid-phase method using a monoreactive DTPA, namely, 1-tert-butyl hydrogen 3,6,9-tris((tert-butoxycarbonyl)methyl)-3,6,9-triazaundecanedioic acid (mDTPA), having only one reactive group, which has previously been synthesized from diethylenetriamine as reported previously. Ltd., Tokyo, Japan), and the mixture was allowed to stand for 1 h at room temperature to obtain L-Phe or carboxy-Phe compound, which was of radiochemical purity of more than 95%.
Electrical property of L-Phe and carboxy-Phe compounds was determined by cellulose acetate electrophoresis (Jokoh, Tokyo, Japan). The lipophilicity was evaluated on the basis of partition coefficient between n-octanol and buffer.
To assess plasma stability, L-Phe compound or carboxyPhe compound was added to freshly prepared murine plasma (male ddY mouse), followed by incubation at 37°C. One and 3 h later, an aliquot was taken from the mixture and subjected to the reverse phase HPLC to determine the amount of intact L-Phe compound or carboxy-Phe compound.
Carboxy-Phe compound was administered to male ddY mice (nϭ5 or 6) via tail vein and blood was collected at predetermined time points. The mice were sacrificed and organs of interest including kidney were removed, weighed, and subjected to measurement of the radioactivity. The urine and feces excreted for 24 h after administration were collected and the radioactivity therein was measured. The same experiment was conducted using L-Phe compound. The urine excreted was analyzed by reverse phase HPLC.
Electrical Property and Lipophilicity The electrophoretic study showed that carboxy-Phe compound was charged more negatively than L-Phe compound at pH of urine and plasma. The comparison of the partition coefficients (noctanol/buffer) revealed that carboxy-Phe compound showed only about 1/9 lipophilicity (2ϫ10 Ϫ4 ) compared to L-Phe compound (17ϫ10
Ϫ4
). These changes resulting from the introduction of carboxy-group would be advantageous to improve the biodistribution of radioactivity. Plasma Stability In vitro incubation study revealed that carboxy-Phe compound remained stable in plasma, by more than 95% at 3 h, similarly to L-Phe compound. When carboxy-Phe or L-Phe compound was administered to mice by intravenous injection, radioactivity was eliminated from blood rapidly. Considering the results obtained in the analyses on plasma and urine together, the majority of the administered compounds were excreted into urine in the intact form, which in turn meant that most compounds were delivered to organs, tissues, etc. without alteration.
Biodistribution of Radioactivity Table 1 shows the radioactivity in organs of mice at 3 h after intravenous administration of L-Phe and carboxy-Phe compounds. Higher radioactivity was observed in kidney than other organs in both compounds; however, renal radioactivity was significantly low in case of carboxy-Phe compound compared to L-Phe compound (about 0.5 vs. 1). The results in Table 1 suggested that the introduction of carboxy-group significantly decreases radioactivity in kidney although it has little effect on the radioactivity distribution in other organs. The changes of radioactivity over time in kidney are depicted in Fig. 2 . As can be seen from Fig. 2 , the renal radioactivity was lower in the mice that received carboxy-Phe compound compared to those received L-Phe compound at every time point examined. This means that the introduction of negative charge into N-terminal amino acid would be effective not only to reduce the radioaccumulation in kidney at the initial stage after administration but also to maintain the radioactivity level lower. The effect of lowering renal accumulation would be attributed to the reduction of lipophilicity and also the repulsive force arisen from negative charge of renal brush border membrane. The present study provides that the introduction of negative charge would constitute a promising method for preventing renal radioaccumulation.
In conclusion, the introduction of negative charge into Nterminal amino acid of 111 In-DTPA-octreotide derivative is considered to be effective to lower the initial renal accumulation after administration as well as to maintain the renal radioactivity at lower level for a long term. Vol. 27, No. 2 
